FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Onconova Therapeutics Inc Announces Encouraging Clinical Data Supporting the Anti-Cancer Activity of the Rigosertib-Nivolumab Combination”
Onconova Therapeutics Inc (NASDAQ: ONTX) surged over 15% in premarket trading after the company announced encouraging clinical data supporting the anti-cancer activity of the Rigosertib-Nivolumab Combination.
The preliminary phase 1/2a trial data show an early signal of activity in extensively pre-treated population with 2 partial responses out of 7 evaluable patients and data supports further development of rigosertib, in combination with immune checkpoint inhibitors in KRAS mutated (KRAS+) non-small cell lung cancer.
Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation.
For more information, please visit: Onconova Therapeutics Inc.
About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.